Literature DB >> 16937531

Microheterogeneity of acute phase proteins in patients with ulcerative colitis.

Marian Grzymisławski1, Katarzyna Derc, Magdalena Sobieska, Krzysztof Wiktorowicz.   

Abstract

AIM: To estimate the serum alpha1-antichymotrypsin (ACT), alpha1-acid glycoprotein (AGP) and transferrin (Tf) concentrations and to evaluate the microheterogeneity of these acute phase proteins in patients with ulcerative colitis.
METHODS: Twenty-seven patients with ulcerative colitis (UC) and 17 healthy control subjects were studied. The patients were categorised as severe (n = 9), moderate (n = 10) and mild groups (n = 8) using Truelove and Witts' classification of ulcerative colitis. Microheterogeneity of ACT, AGP and Tf was analysed by crossed immunoaffinity electrophoresis (CIAE) with concanavalin A. In all serum samples standard electrophoresis of serum proteins was performed, iron (Fe) concentration, total iron binding capacity (TIBC) and C-reactive protein (CRP) were also measured.
RESULTS: Our patients suffering from ulcerative colitis had significantly higher serum ACT and AGP concentrations and lower serum transferrin concentration in comparison to healthy subjects. Changes in concentrations of acute phase proteins were dependent on the activity of the inflammatory process. The glycosylation patterns of transferrin were related to the inflammation status. We also observed the correlation between ACT and AGP concentrations, patterns of transferrin glycosylation and changes in standard protein electrophoresis or blood cell count.
CONCLUSION: The glycosylation patterns of transferrin obtained from patients suffering from ulcerative colitis are highly branched and sialylated compared with those obtained from healthy subjects. In contrast, the glycosylation patterns of transferrin do not differ according to the activity index of ulcerative colitis. The microheterogeneity patterns of AGP and ACT are similar in ulcerative colitis patients and healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937531      PMCID: PMC4088018          DOI: 10.3748/wjg.v12.i32.5191

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  20 in total

Review 1.  Established and emerging biological activity markers of inflammatory bowel disease.

Authors:  O H Nielsen; B Vainer; S M Madsen; J B Seidelin; N H Heegaard
Journal:  Am J Gastroenterol       Date:  2000-02       Impact factor: 10.864

Review 2.  Selectins: interpreters of cell-specific carbohydrate information during inflammation.

Authors:  L A Lasky
Journal:  Science       Date:  1992-11-06       Impact factor: 47.728

Review 3.  Glycan microheterogeneity forms of alpha 1-acid glycoprotein (AGP): their identification in biological fluids and variations in their relative proportions in disease states.

Authors:  J Agneray
Journal:  Prog Clin Biol Res       Date:  1989

Review 4.  Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation.

Authors:  T Arndt
Journal:  Clin Chem       Date:  2001-01       Impact factor: 8.327

5.  Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.

Authors:  M Z Mazlam; H J Hodgson
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

6.  A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease.

Authors:  E Louis; J Belaiche; C van Kemseke; D Franchimont; D de Groote; V Gueenen; J Y Mary
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-10       Impact factor: 2.566

7.  Protective effects of sialylated oligosaccharides in immune complex-induced acute lung injury.

Authors:  M S Mulligan; J B Lowe; R D Larsen; J Paulson; Z L Zheng; S DeFrees; K Maemura; M Fukuda; P A Ward
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

8.  Con A-nonreactive human alpha 1-acid glycoprotein (AGP) is more effective in modulation of lymphocyte proliferation than Con A-reactive AGP serum variants.

Authors:  O Pos; R A Oostendorp; M E van der Stelt; R J Scheper; W Van Dijk
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

9.  Relationship between the tumor necrosis factor alpha polymorphism and the serum C-reactive protein levels in inflammatory bowel disease.

Authors:  Agnes Vatay; László Bene; Agota Kovács; Zoltán Prohászka; Csaba Szalai; László Romics; Béla Fekete; István Karádi; George Füst
Journal:  Immunogenetics       Date:  2003-06-14       Impact factor: 2.846

10.  Adaptation of transferrin protein and glycan synthesis.

Authors:  G de Jong; W L van Noort; R A Feelders; C M de Jeu-Jaspars; H G van Eijk
Journal:  Clin Chim Acta       Date:  1992-11-16       Impact factor: 3.786

View more
  1 in total

1.  Transferrin changes in haemodialysed patients.

Authors:  Dorota Formanowicz; Piotr Formanowicz
Journal:  Int Urol Nephrol       Date:  2011-04-01       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.